Topics
September 2014 | Editors' Page
What Is the Limit of Imaging?
Allen C. Ho, MD, and Robert L. Avery, MD
May/June 2014 | Editors' Page
Refining AMD Management
October 2013 | Editors' Page
ORBIS: Not Just the Flying Eye Hospital
Rachel M. Renshaw, Editor-in-Chief
October 20, 2026
EyePoint to Shift Focus, Cut Workforce Following Phase 3 Duravyu Results
October 19, 2026
Second Phase 3 Trial of Duravyu in Wet AMD Misses Primary Endpoint
October 16, 2026
Alvotech and Advanz Pharma Submit European Application for First Proposed Eylea 8 mg Biosimilar
FDA Approves Genentech's Enspryng as First At-Home Subcutaneous Treatment for Thyroid Eye Disease
October 2026 Insert
Editorially Independent Content, Supported With Advertising From Asetllas
Editorially independent supported by Abbvie and Regenxbio
Free Print Subscription
Email Newsletter
Conference Calendar
